Thrombotic microangiopathy (TMA) after kidney transplantation is a rare but severe complication, significantly affecting long-term patient and graft survival. The reasons for the development of TMA in a transplant are varied, and patient management depends on its nature. Kidney biopsy allows to suspect TMA, in many cases. However, it is not always possible to unambiguously verify TMA and clarify its cause based on biopsy data.
No takes yet. Share an insight, caveat, or question.
Stolyarevich et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: